本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

33.22
-0.3800-1.13%
盤後33.220.00000.00%19:30 EDT
成交量:79.45萬
成交額:2,644.27萬
市值:19.76億
市盈率:-4.74
高:34.36
開:33.83
低:32.89
收:33.60
52周最高:46.00
52周最低:22.24
股本:5,947.16萬
流通股本:5,008.85萬
量比:1.05
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
淨資產收益率:-34.34%
總資產收益率:-22.24%
市淨率:1.93
市盈率(LYR):-4.67

資料載入中...

2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/04

重要事件披露

8-K - Current report
2023/04/19

重要事件披露

8-K - Current report